About: Gemcitabine/carboplatin in advanced non-small cell lung cancer     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Gemcitabine/cisplatin is among the most widely used regimens inEurope for first-line treatment of non-small cell lung cancer (NSCLC). Problems with cisplatin use in this setting include significant nonhematologie toxicity and difficulty of use in outpatiCarboplatin constitutes a reasonable alternative to cisplatin in this combination, since it showa synergy with gemcitabine in vitro, is easier to use in ambulatory patients, and has a better nonhematolgic toxicity profile. Studies of gemcitabine/cisplation a 28-day shedule (e.g. gemcitabine on days 1, 8, 15 and carboplatin on day 1)generally indicate excessive thrompocytopenia. Use of 21 day shedule (e.g. gemcitabine on days 1 and 8, carboplatin on day 1) is associated with reduced toxicity andcomparable efficiacy.
  • Gemcitabine/cisplatin is among the most widely used regimens inEurope for first-line treatment of non-small cell lung cancer (NSCLC). Problems with cisplatin use in this setting include significant nonhematologie toxicity and difficulty of use in outpatiCarboplatin constitutes a reasonable alternative to cisplatin in this combination, since it showa synergy with gemcitabine in vitro, is easier to use in ambulatory patients, and has a better nonhematolgic toxicity profile. Studies of gemcitabine/cisplation a 28-day shedule (e.g. gemcitabine on days 1, 8, 15 and carboplatin on day 1)generally indicate excessive thrompocytopenia. Use of 21 day shedule (e.g. gemcitabine on days 1 and 8, carboplatin on day 1) is associated with reduced toxicity andcomparable efficiacy. (en)
Title
  • Gemcitabine/carboplatin in advanced non-small cell lung cancer
  • Gemcitabine/carboplatin in advanced non-small cell lung cancer (en)
skos:prefLabel
  • Gemcitabine/carboplatin in advanced non-small cell lung cancer
  • Gemcitabine/carboplatin in advanced non-small cell lung cancer (en)
skos:notation
  • RIV/00023841:_____/02:00005571!RIV/2003/MZ0/L18003/N
http://linked.open.../vavai/riv/strany
  • 29-42
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(NC6070)
http://linked.open...iv/cisloPeriodika
  • 18
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 646843
http://linked.open...ai/riv/idVysledku
  • RIV/00023841:_____/02:00005571
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • gemcitabine;carboplatin;non-small cell lung cancer (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • NL - Nizozemsko
http://linked.open...ontrolniKodProRIV
  • [A420EC9C7FD6]
http://linked.open...i/riv/nazevZdroje
  • Investigational New Drugs
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • neuveden
http://linked.open...iv/tvurceVysledku
  • Zatloukal, Petr
number of pages
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software